QNRX supply chain intelligence for Quoin Pharmaceuticals, Ltd.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Quoin Pharmaceuticals, Ltd. (QNRX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| SKINVISIBLE-PHARMACEUTICALS-INC | SKINVISIBLE-PHARMACEUTICALS-INC | 92% | Under which Skinvisible granted us an exclusive royalty-bearing license relating to the production and manufacture of prescription drug products |
| CONTRACT-MANUFACTURER-OF-THE-DRUG-PRODUCT-FOR-CL | CONTRACT-MANUFACTURER-OF-THE-DRUG-PRODUCT-FOR-CL | 90% | The Company is also dependent on several third party suppliers, in some cases a single source supplier including the contract manufacturer of the drug product for clinical development |
| CONTRACT-RESEARCH-ORGANIZATION | CONTRACT-RESEARCH-ORGANIZATION | 90% | The Company is also dependent on several third party suppliers, in some cases a single source supplier including the contract research organization managing both of the Company’s current clinical studies |
| SUPPLIER-OF-THE-ACTIVE-PHARMACEUTICAL-INGREDIENT | SUPPLIER-OF-THE-ACTIVE-PHARMACEUTICAL-INGREDIENT | 90% | The Company is also dependent on several third party suppliers, in some cases a single source supplier including the supplier of the active pharmaceutical ingredient (API) |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| EVESTIA-CLINICAL-LIMITED | EVESTIA-CLINICAL-LIMITED | 62% | equity financings. We incurred net losses of approximately $5.0 million and negative cash flows from operations of $4.9 million for the three months ended March 31, 2026. At March 31, 2026, we had ca… |
| QUOIN-PHARMACEUTICALS-LTD | QUOIN-PHARMACEUTICALS-LTD | 62% | Item 1A, “Risk Factors” of our Form 10-K. You should carefully consider the factors discussed in our Form 10-K, which could materially affect our business, financial condition or future results. The … |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| QNRX-DEBT | Debt stack $2.2M | 90% | Market cache reports total debt of $2.2M. |
| QNRX-DEBT-11999 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2021-12-31. |
| QNRX-DEBT-11998 | Warrants outstanding: 16.13 | 90% | xbrl warrant detail from xbrl 2025-10-14. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| QNRX-OWNER-AIGH-CAPITAL-MANAGEMENT-LLC | AIGH Capital Management LLC | 95% | 13F/ownership overlay lists AIGH Capital Management LLC; shares held 49,323; ownership 5.88%; value $316,160; as of 2025-12-31. |
| QNRX-OWNER-BOOTHBAY-FUND-MANAGEMENT-LLC | Boothbay Fund Management, LLC | 95% | 13F/ownership overlay lists Boothbay Fund Management, LLC; shares held 59,838; ownership 7.13%; value $383,561; as of 2025-12-31. |
| QNRX-OWNER-SUMMITTX-CAPITAL-L-P | Summittx Capital, L.P. | 95% | 13F/ownership overlay lists Summittx Capital, L.P.; shares held 64,795; ownership 7.72%; value $415,335; as of 2025-12-31. |
| QNRX-OWNER-MILLENNIUM-MANAGEMENT-LLC | Millennium Management Llc | 95% | 13F/ownership overlay lists Millennium Management Llc; shares held 74,817; ownership 8.92%; value $479,576; as of 2025-12-31. |
| QNRX-OWNER-RESOLUTE-CAPITAL-ASSET-PARTNERS-LLC | Resolute Capital Asset Partners Llc | 95% | 13F/ownership overlay lists Resolute Capital Asset Partners Llc; shares held 30,000; ownership 3.58%; value $192,299; as of 2025-12-31. |
| QNRX-OWNER-STONEPINE-CAPITAL-MANAGEMENT-LLC | Stonepine Capital Management, LLC | 95% | 13F/ownership overlay lists Stonepine Capital Management, LLC; shares held 78,189; ownership 9.32%; value $501,191; as of 2025-12-31. |
| QNRX-OWNER-ABERDEEN-GROUP-PLC | Aberdeen Group plc | 95% | 13F/ownership overlay lists Aberdeen Group plc; shares held 75,000; ownership 8.94%; value $480,749; as of 2025-12-31. |
| QNRX-OWNER-WOODLINE-PARTNERS-LP | Woodline Partners LP | 95% | 13F/ownership overlay lists Woodline Partners LP; shares held 79,582; ownership 9.49%; value $510,120; as of 2025-12-31. |
| QNRX-OWNER-IKARIAN-CAPITAL-LLC | Ikarian Capital, LLC | 95% | 13F/ownership overlay lists Ikarian Capital, LLC; shares held 211,538; ownership 25.21%; value $1.4M; as of 2025-12-31. |
| QNRX-OWNER-ADAR1-CAPITAL-MANAGEMENT-LLC | Adar1 Capital Management, LLC | 95% | 13F/ownership overlay lists Adar1 Capital Management, LLC ; shares held 58,230; ownership 6.94%; value $373,254; as of 2025-12-31. |